Literature DB >> 20676024

Pathways of oncogene-induced senescence in human melanocytic cells.

Rajat Bansal1, Mikhail A Nikiforov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20676024      PMCID： PMC3040961          DOI： 10.4161/cc.9.14.12551

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  74 in total

Review 1.  Transcriptional activation by the Myc oncoprotein.

Authors:  M D Cole; M A Nikiforov
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

2.  Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.

Authors:  Jürgen Bauer; John A Curtin; Dan Pinkel; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2006-08-03       Impact factor: 8.551

3.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.

Authors:  Raffaella Di Micco; Marzia Fumagalli; Angelo Cicalese; Sara Piccinin; Patrizia Gasparini; Chiara Luise; Catherine Schurra; Massimiliano Garre'; Paolo Giovanni Nuciforo; Aaron Bensimon; Roberta Maestro; Pier Giuseppe Pelicci; Fabrizio d'Adda di Fagagna
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

4.  DEK Expression is controlled by E2F and deregulated in diverse tumor types.

Authors:  Maria Stella Carro; Fabio Mario Spiga; Micaela Quarto; Valentina Di Ninni; Sara Volorio; Myriam Alcalay; Heiko Müller
Journal:  Cell Cycle       Date:  2006-06-01       Impact factor: 4.534

5.  The power and the promise of oncogene-induced senescence markers.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

6.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 7.  Human polynucleotide phosphorylase (hPNPase old-35): an RNA degradation enzyme with pleiotrophic biological effects.

Authors:  Devanand Sarkar; Paul B Fisher
Journal:  Cell Cycle       Date:  2006-05-15       Impact factor: 4.534

Review 8.  MITF: master regulator of melanocyte development and melanoma oncogene.

Authors:  Carmit Levy; Mehdi Khaled; David E Fisher
Journal:  Trends Mol Med       Date:  2006-08-08       Impact factor: 11.951

9.  Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.

Authors:  Christophe Denoyelle; George Abou-Rjaily; Vladimir Bezrookove; Monique Verhaegen; Timothy M Johnson; Douglas R Fullen; Jenny N Pointer; Stephen B Gruber; Lyndon D Su; Mikhail A Nikiforov; Randal J Kaufman; Boris C Bastian; Maria S Soengas
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

10.  Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

Authors:  V C Gray-Schopfer; S C Cheong; H Chong; J Chow; T Moss; Z A Abdel-Malek; R Marais; D Wynford-Thomas; D C Bennett
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640
View more
  21 in total

1.  New functions for the Snail family of transcription factors: Two-faced proteins.

Authors:  Jesús Pérez-Losada; Isidro Sanchez-Garcia
Journal:  Cell Cycle       Date:  2010-07-15       Impact factor: 4.534

Review 2.  Controversial aspects of oncogene-induced senescence.

Authors:  Anna Bianchi-Smiraglia; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

3.  Detection of Nucleotide Disbalance in Cells Undergoing Oncogene-Induced Senescence.

Authors:  Mikhail A Nikiforov; Donna S Shewach
Journal:  Methods Mol Biol       Date:  2017

Review 4.  The Immortal Senescence.

Authors:  Anna Bianchi-Smiraglia; Brittany C Lipchick; Mikhail A Nikiforov
Journal:  Methods Mol Biol       Date:  2017

5.  Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1 pathways.

Authors:  Maria Zamkova; Natalia Khromova; Boris P Kopnin; Pavel Kopnin
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

6.  8-Cl-cAMP and PKA I-selective cAMP analogs effectively inhibit undifferentiated thyroid cancer cell growth.

Authors:  Elisa Stellaria Grassi; Alessandra Dicitore; Irene Negri; Maria Orietta Borghi; Giovanni Vitale; Luca Persani
Journal:  Endocrine       Date:  2016-07-27       Impact factor: 3.633

7.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

8.  Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAFV600E expression.

Authors:  Tengyu Ko; Rahul Sharma; Shisheng Li
Journal:  Oncogene       Date:  2019-09-23       Impact factor: 9.867

9.  Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma.

Authors:  Valentina Bevelacqua; Ylenia Bevelacqua; Saverio Candido; Evangelia Skarmoutsou; Alfredo Amoroso; Claudio Guarneri; Angela Strazzanti; Pietro Gangemi; Maria C Mazzarino; Fabio D'Amico; James A McCubrey; Massimo Libra; Grazia Malaponte
Journal:  Oncotarget       Date:  2012-08

Review 10.  Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.

Authors:  Albert E Berman; Olga V Leontieva; Venkatesh Natarajan; James A McCubrey; Zoya N Demidenko; Mikhail A Nikiforov
Journal:  Oncotarget       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.